Blog
RSS FeedPosted by Michael Wonder on 25 Nov 2021
Medicines Australia welcomes tabling of parliamentary report about approval processes for new drugs and novel medical technologies
25 November 2021 - Medicines Australia welcomes the House of Representatives Health, Aged Care and Sport Committee Inquiry report into ...
Posted by Michael Wonder on 24 Nov 2021
Agenda for the March 2022 PBAC meeting
24 November 2021 - The agenda for the March 2022 PBAC meeting is now available. ...
Posted by Michael Wonder on 24 Nov 2021
Semaglutide (Wegovy) stakeholder meeting outcome statement
24 November 2021 - The outcome statement for the semaglutide stakeholder meeting held on 26 August 2021 is now available. ...
Posted by Michael Wonder on 22 Nov 2021
New PBS listing helps Australians with rare genetic condition
21 November 2021 - From 1 December 2021, Australians with a rare and potentially deadly condition, hereditary angioedema, will be able ...
Posted by Michael Wonder on 21 Nov 2021
Rare condition medication going on PBS
21 November 2021 - From next month a medication for a rare and potentially deadly genetic condition with be available ...
Posted by Michael Wonder on 15 Nov 2021
Supporting Australians with rare stomach and bowel cancer
15 November 2021 - The Morrison Government will list Qinlock (ripretinib) on the PBS for the treatment of advanced gastro-intestinal stromal ...
Posted by Michael Wonder on 14 Nov 2021
Rare cancer drug to be subsidised
14 November 2021 - A drug to treat a rare stomach and bowel cancer will be subsidised after being listed ...
Posted by Michael Wonder on 13 Nov 2021
Public Summary Documents (first time rejections and deferrals) – July 2021 PBAC meeting
12 November 2021 - The Public Summary Documents (first time rejections and deferrals) from the July 2021 PBAC meeting are now ...
Posted by Michael Wonder on 12 Nov 2021
Progress update: post-market review of medicines for smoking cessation
12 November 2021 - In June 2021, the Drug Utilisation Sub-Committee and the Economics Sub-Committee of the PBAC considered the report ...
Posted by Michael Wonder on 06 Nov 2021
Pharmaceutical Benefits Scheme continued dispensing arrangements
5 November 2021 - The Australian Government has extended the Continued Dispensing emergency arrangements until 30 June 2022, when they ...
Posted by Michael Wonder on 05 Nov 2021
Drug Utilisation Sub-Committee outcome statement
5 November 2021 - The Outcome Statement from the October 2021 Drug Utilisation SubCommittee meeting is now available. ...
Posted by Michael Wonder on 03 Nov 2021
Department of Health tweaks agenda for this week's PBAC meeting
1 November 2021 - This is the tenth revision to the agenda for this week's PBAC meeting. ...
Posted by Michael Wonder on 01 Nov 2021
Australia to subsidise multiple myeloma drug Darzalex under PBS
31 October 2021 - Blood cancer patients will be among those to benefit with better access to medicine under the Pharmaceutical ...
Posted by Michael Wonder on 31 Oct 2021
Prostate cancer treatment to be put on PBS
31 October 2021 - For the first time in seven years, a prostate cancer therapy will be added to the ...
Posted by Michael Wonder on 31 Oct 2021
Schedule of Pharmaceutical Benefits - 1 November 2021 update
1 November 2021 - The November 2021 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...